Network pharmacology is a new science and is becoming a new way for TCM study.
Network pharmacology combines with TCM is a new medical research model.
The network pharmacology approach is capable of describing complex interactions among biological system, drugs, and diseases, such as cancer from a network perspective. It helps us to understand how herbal medicine works on people with cancer and how a new indication of a given herbal formula can be predicted.
Traditional Chinese Medicine (TCM) emphasizes integrity and systematicity. Chinese Herbal Medicine (CHM) is characterized by multi-component, multi-target, multi-channel complex action. Cancer belongs to polygenic disease, and it is characteristic of complex traits of the disease which is determined by multiple genes. Network pharmacology integrates disease network, drug network, and biological system network, analyzes the interaction among diseases, drugs and specific nodes in the network, and studies the pathogenesis of cancer, the action mechanism of drugs and compatibility principle of prescription. In the field of cancer, by applying concepts and methods of network pharmacology, we are expected to find new type drugs-“biological networks regulatory drug”. It is helpful for individualized treatment, improved prognosis, and therapeutic effect.